Synthesis of Novel γ-Aminobutyric Acid (GABA) Uptake Inhibitors. 5. Preparation and Structure−Activity Studies of Tricyclic Analogues of Known GABA Uptake Inhibitors
作者:Knud Erik Andersen、Jan L. Sørensen、Jesper Lau、Behrend F. Lundt、Hans Petersen、Per O. Huusfeldt、Peter D. Suzdak、Michael D. B. Swedberg
DOI:10.1021/jm990513k
日期:2001.6.1
On the basis of the SAR of a series of known gamma-aminobutyric acid (GABA) uptake inhibitors, including 4 (SKF 89976), new tricyclic analogues have been prepared. These novel compounds are derivatives of nipecotic acid, guvacine, and homo-beta-proline, substituted at the nitrogen of these amino acids by various lipophilic moieties such as (10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)alkoxyalkyl or (10
基于一系列已知的γ-氨基丁酸(GABA)摄取抑制剂(包括4种(SKF 89976))的SAR,已制备了新的三环类似物。这些新颖的化合物是乳香酸,番石榴碱和高β-脯氨酸的衍生物,在这些氨基酸的氮上被各种亲脂性部分所取代,例如(10,11-dihydro-5H-dibenz [b,f] azepin-5 -基)烷氧基烷基或(10,11-二氢-5H-二苯并[a,d]环庚基-5-亚烷基)烷氧基烷基。确定了该新系列中每种化合物抑制大鼠突触小体中[(3)H] -GABA吸收的体外值,并且发现几种新型化合物显示出与参考化合物相当的高效价4、5(替加滨)和6(CI-966)。还评估了几种新型化合物的体内抑制15 mg / kg(ip)剂量的6,7-二甲氧基-4-乙基-β-咔啉-3-羧酸甲酯(DMCM)诱发的阵挛性癫痫发作的能力。 。一种化合物是(R)-1-(2-(2-(2-(10,11-二氢-5H-二苯并[b,f]